Multiple MyelomaPhase 1NCT07377435
DC/MM Fusion Vaccine
DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM
265 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Leukemia, lymphoma, and myeloma265 studies
Multiple MyelomaPhase 1NCT07377435
DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM
Non Hodgkin LymphomaPhase 1/2NCT06768905
IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL
Acute Myeloid LeukemiaPhase 1NCT07374029
Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML
Large B-Cell Lymphoma (LBCL)Phase 1NCT07361224Papers
Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive Large B Cell Lymphoma at Lymphodepletion
Acute Myeloid Leukemia and High-Grade Myeloid NeoplasmsPhase 1/2NCT04797767Papers
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
Relapsed or Refractory Multiple MyelomaPhase 1NCT07032714
Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma
B-cell Lymphoma RefractoryPhase 1/2NCT07319676Papers
Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas
Relapsed/Refractory Multiple MyelomaPhase 1/2NCT06536413Papers
ATRA and Carfilzomib in Plasma Cell Myeloma Patients
Relapsed or Refractory Hodgkin Lymphoma and CD30+ LymphomasPhase 1NCT05544968
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Acute Myeloid LeukemiaPhase 1NCT03533816Papers
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
Newly Diagnosed NPM1- and FLT3-Mutated AMLPhase 1NCT06313437
Revumenib in Combination With 7+3 + Midostaurin in AML
Relapsed or Refractory Acute Myeloid LeukemiaPhase 1NCT05627232
Tazemetostat and Palbociclib With CPX-351for R/R AML
High-Risk Large B-Cell Lymphoma After Cellular TherapyPhase 1/2NCT05256641
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
Acute Myeloid LeukemiaPhase 1NCT05748197Papers
ADCLEC.syn1 in People With Acute Myeloid Leukemia
Acute Myeloid Leukemia and Myelodysplastic SyndromePhase 1NCT07283094Papers
FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia
EBV-Positive Hodgkin and Non-Hodgkin LymphomaPhase 1NCT01555892Papers
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
Relapsed/Refractory B-Cell Non-Hodgkin LymphomaPhase 1NCT06209619
CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma
Newly Diagnosed Acute Myeloid LeukemiaPhase 1NCT05558124
CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
Relapsed or Refractory Large B-Cell LymphomaPhase 1NCT05755087
Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma
Relapsed/Refractory Acute Myeloid LeukemiaPhase 1/2NCT05580601
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)
Non Hodgkin Lymphoma (NHL)Phase 1/2NCT04186520Papers
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Relapsed or Refractory Chronic Lymphocytic LeukemiaPhase 1/2NCT06644183
Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)
Relapsed/Refractory Multiple MyelomaPhase 1NCT07093554
Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma
B-cell Acute Lymphoblastic LeukemiaPhase 1NCT06559189Papers
CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL